Mochu v. Advocate Aurora Health, Inc.

CourtDistrict Court, N.D. Illinois
DecidedAugust 2, 2023
Docket1:20-cv-07035
StatusUnknown

This text of Mochu v. Advocate Aurora Health, Inc. (Mochu v. Advocate Aurora Health, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mochu v. Advocate Aurora Health, Inc., (N.D. Ill. 2023).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

Martin Mochu,

Plaintiff, No. 20 CV 7035 v. Judge Lindsay C. Jenkins Advocate Aurora Health, Inc.,

Defendant MEMORANDUM OPINION AND ORDER

Mochu Martin Mochu (“Plaintiff” or “Mochu”) brings suit against Advocate Aurora Health, Inc. (“Defendant” or “Advocate”), for employment discrimination in violation of Title VII of the Civil Rights Act of 1964. Currently before the Court is Defendant’s motion for summary judgment [Dkt. 49]. The motion is granted in part and denied in part. Mochu’s Title VII claims for discrimination and retaliation are limited to the adverse employment action of Defendant’s decision to deny Mochu a promotion to technical specialist in 2022. Mochu’s hostile work environment claim is also limited to the period after Stephanie Kuhn became Mochu’s supervisor in early 2019. Defendant’s motion for summary judgment is otherwise denied. I. Background The following facts are taken from Defendants’ Local Rule (L.R.) 56.1 statement and the exhibits filed with that statement [Dkts. 34 through 39, 50, 51], as well as from the affidavits that Mochu attaches to his response brief. [See Dkts. 64-1 through 64-5.] These facts are undisputed except where a dispute is noted.1

1 Summary judgment briefing in this case was conducted pursuant to the previously assigned judge’s Standing Order on Summary Judgment Practice. That Order requires Mochu is a resident of Illinois. He was born in Nigeria and speaks with an accent. He obtained his undergraduate degree in biomedical sciences and became a certified cytotechnologist in 1993. In December 2012, Mochu applied for and obtained

a position as a cytotechnologist at ACL Laboratories, which is a part of Advocate. Initially, Mochu’s job consisted primarily of screening gynecologic slides for malignancies to determine the presence of abnormal, precancerous or cancerous cells. The cytology department is a department of approximately twenty-five team members including lab assistants, data entry team members and cytotechnologists. Mochu was the only Black cytotechnologist when he was hired in 2013. At the time

Mochu was hired, the supervisor of the Cytology department was Donna Shelk

parties to file a joint statement of undisputed material fact. If the parties disagree on whether certain facts are undisputed, “they may file a joint motion prior to filing the motion for summary judgment so the Court can determine whether there is a basis for the alleged disputes.” Id. The parties were not permitted to file separate statements of undisputed fact. However, the non-movant is allowed to “include facts in its response to the motion for summary judgment that it contends are disputed in order to demonstrate that a genuine issue of material fact exists that warrants denying the motion for summary judgment.” Id. The non-movant “must include citations to supporting materials” and attach those materials to its brief, and the movant “may respond to those facts in its reply.” Id. Prior to moving for summary judgment, Defendant filed a motion seeking to resolve the parties’ impasse regarding whether there was a basis to dispute certain statements of fact. [See Dkt. 44.] The Court issued an order overruling all of Mochu’s objections to Defendant’s proposed facts and sustaining some and overruling some of Defendant’s objections to Mochu’s proposed facts. [See Dkt. 47.] Defendant subsequently prepared its Local Rule (L.R.) 56.1 statement of undisputed material facts in accordance with the ruling on the parties’ objections. [See Dkt. 51 (sealed version).] At the time of filing, Mochu’s counsel had not responded to Defense counsel’s request to approve the draft. [See id. at 1.] In his summary judgment response brief, Mochu does not raise any objections to the joint statement of facts prepared by Defendant; therefore, the Court considers all of the facts set forth in that document [Dkt. 51] to be undisputed, with one caveat. Since the Standing Order on Summary Judgment Practice allows Mochu to raise factual disputes by alleging them in his response brief and attaching supporting exhibits, the Court will also consider Mochu’s affidavits in determining whether there are material factual disputes that preclude summary judgment. (“Shelk”). Shelk’s supervisor was Debra Ortiz (“Ortiz”), who was the director of both the cytology and histology departments. [See Dkt. 37 at 5-6 (Tr. 9:16-10:6).] Shelk was assisted by Stephanie Kuhn (“Khun”), who held the title of technical specialist.

A technical specialist is a higher-level role than a cytotechnologist. Shelk and Kuhn are both white and American. Advocate employees are hired subject to a 90-day probationary period during which time the supervisor and the new employee assess the ability of the new employee to perform the position. During the probationary period, the employment relationship may be terminated by either party without notice. In April 2013, at the

end of Mochu’s probationary period, Shelk gave Mochu a performance review. Mochu received an overall rating of “significantly exceeds expectations.” [Dkt. 51, ¶ 12.] In his next performance review at the end of 2013, Shelk evaluated Mochu as “exceeds expectations.” [Id., ¶ 14.] Mochu was satisfied with both of these evaluations. According to Mochu, when he began at Advocate all of the other employees in the cytology department were afraid of Shelk and Kuhn and “[n]obody was speaking.” [Dkt. 51, ¶ 17.] Former cytotechnologist Aimee Hilden (“Hilden”), who is white, told

Mochu that there was a lunch “clique” that included Shelk, Kuhn and a few other white employees who ate together in the employee lounge. Hilden told Mochu that she heard Kuhn say that “they can’t get a good feeling” about Mochu and “we need to get rid of this guy.” [Dkt. 34-1 at 34 (Tr. 124:20-125:12).] According to Mochu, this talk made Hilden “so uncomfortable” that “she left the lunch table.” [Id.] Mochu did not hear the comments directly and did not know if Kuhn spoke of other employees the same way. According to Mochu, he never heard Shelk make any racist comments but another cytotechnologist, Cara Root (“Root”) told Mochu that Shelk used the “N word” all the time. [Dkt. 51, ¶ 102.]

Mochu and other employees informed the on-site human resources consultant, Jeana Chammas (“Chammas”) that there was a perception that lunch breaks were not inclusive. According to Chammas, Hilden stated that “she was uncomfortable because there was personal chatter going on with the group.” [Dkt. 36 at 9 (Tr. 22:15- 21).] Chammas spoke with Shelk about how she “needs to make sure that she’s inclusive and her having lunch meal breaks with team members in her group was not

being perceived as being inclusive.” [Id.] Chammas also testified that Mochu shared with her that there had been inappropriate discussions about his hair. Mochu believed this difference in treatment was racially motivated. Chammas testified that she would “provide coaching to the leader to ensure that that topic wouldn’t be discussed moving forward.” [Dkt. 36 at 7 (Tr. 15:9–16:13); see also Dkt. 51, ¶¶ 21-22.] In late 2013 or early 2014, Mochu read a slide and diagnosed it “negative.”

Shelk, Kuhn and Technical Specialist Mary Bogart took the slide to then-Medical Director Dr. Jamie Walloch (“Walloch”), who changed the diagnosis to “high grade.” A pathologist eventually reviewed the slide and agreed with Mochu, diagnosing “negative atrophy.” [Dkt. 51, ¶ 23.] Mochu asked Shelk to remove mention of this incident from his record, but Shelk refused. Mochu “knew it affected his evaluation.” [Id.] Mochu also explains that the changed diagnosis required the patient to undergo additional, painful biopsies, which ultimately proved to be unnecessary when the pathologist concurred in Mochu’s reading.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Harris v. Forklift Systems, Inc.
510 U.S. 17 (Supreme Court, 1993)
National Railroad Passenger Corporation v. Morgan
536 U.S. 101 (Supreme Court, 2002)
Groesch v. City of Springfield, Ill.
635 F.3d 1020 (Seventh Circuit, 2011)
Ellis v. CCA OF TENNESSEE LLC
650 F.3d 640 (Seventh Circuit, 2011)
Barton v. Zimmer, Inc.
662 F.3d 448 (Seventh Circuit, 2011)
Denise Coleman v. Patrick R. Donaho
667 F.3d 835 (Seventh Circuit, 2012)
Mary Nell Little v. Cox's Supermarkets
71 F.3d 637 (Seventh Circuit, 1995)
Diann Grube v. Lau Industries, Inc.
257 F.3d 723 (Seventh Circuit, 2001)
Will Tinner v. United Insurance Company of America
308 F.3d 697 (Seventh Circuit, 2002)
Barbara Payne v. Michael Pauley
337 F.3d 767 (Seventh Circuit, 2003)
Brenda O'Neal v. City of Chicago and Jerry Robinson
392 F.3d 909 (Seventh Circuit, 2004)
Chrissie Washington v. Illinois Department of Revenue
420 F.3d 658 (Seventh Circuit, 2005)
Renee Majors v. General Electric Company
714 F.3d 527 (Seventh Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Mochu v. Advocate Aurora Health, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/mochu-v-advocate-aurora-health-inc-ilnd-2023.